The current results were consistent with a previous report of ccRCC that linked EPO expression to the TMN stage and nuclear grades in ccRCC samples, while strong significance was observed in the early-stage group (T1G1), suggesting that EPO overexpression in the early stages of the tumor may play a crucial role in promoting cell proliferation [6]. The gene discussed is EPO; the disease is nonpapillary renal cell carcinoma.